the effect of short-term intensive cyclophosphamide therapy upon 21 patients with moderately advanced multiple sclerosis is compared with a non-treated control group of 21 patients retrospectively matched for global disability .
C0010583
cyclophosphamide
C0026769
multiple sclerosis